EAM Global Investors’s OptimizeRx OPRX Stock Holding History

EAM Global Investors’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52,829	Closed	-$4.52M	–	242
2021 Q3	$4.52M	Buy	52,829 +17,410	+49%	+$1.09M	1.07%	10
2021 Q2	$2.19M	Hold	35,419	–	–	0.61%	93
2021 Q1	$1.73M	Sell	35,419 -69,563	-66%	-$3.36M	0.48%	118
2020 Q4	$3.27M	Hold	104,982	–	–	0.89%	30
2020 Q3	$2.19M	Buy	+104,982	New	+$1.8M	0.8%	51

Other funds holding OPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

EAM Global Investors's OPRX Position: Q4 2021 in Review

EAM Global Investors sold out of OptimizeRx (OPRX) in Q4 2021, closing a stake of 52,829 shares — an estimated $4.52M sold.

EAM Global Investors first reported a position in OPRX in Q3 2020 and held it in 5 quarters. The position peaked at $4.52M in Q3 2021. 180 funds tracked by Wall St. Rank hold OPRX as of Q4 2021.

EAM Global Investors reported no remaining OptimizeRx position as of Q4 2021 after selling out during the quarter.
EAM Global Investors sold 52,829 OptimizeRx shares in Q4 2021, an estimated $4.52M.
EAM Global Investors first reported a position in OptimizeRx in Q3 2020 and held it in 5 quarters.
EAM Global Investors's OptimizeRx position peaked at $4.52M in Q3 2021.
180 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2021.

Based on EAM Global Investors's 13F filing for Q4 2021, filed 11 Feb 2022.